System for compounding and packaging ready to reconstitute ophthalmic drug powders to a solution or to a suspension for administration to an eye of patient

1. A system for sterilely mixing compounds to provide an ophthalmic compound and configured to directly administer the mixed compounds from a mixing vessel to an eye of a patient, comprising:

a first container for containing a first compound, the first container having a collar defining an opening;

a membrane disposed over the opening of the container, wherein the membrane is capable of being punctured in order to provide fluid communication to an interior of the container;

a sleeve sized and shaped to removably engage the collar of the first container;

a puncture member disposed on a first side of the sleeve, the puncture member sized and shaped to puncture the membrane in a first condition in which the sleeve is engaged with the collar;

a luer lock disposed on a second side of the sleeve opposite the first side, the luer lock and the puncture member define a fluid communication passage such that fluid can be delivered through the luer lock and the puncture member and into the container;

a vent member that provides a fluid communication passage through a wall of the sleeve such that when the sleeve is in a first condition and engaged with the collar of the container, air can be expelled from the container through the vent as fluid is introduced into the container through the luer lock, wherein the length of the vent is smaller than the diameter of the sleeve;

a dropper tip that is sized and shaped to removably engage the collar such that the dropper tip can be attached to the first container with the sleeve removed from the first container, the dropper tip having a static open lumen and permitting controlled dispensing of a mixture of the first compound and a fluid that has been previously introduced through the luer lock; and

a drain port disposed on an underside if the dropper tip, the drain port being sized and shaped to pass through the membrane and provides a fluid communication passage through the drain port to a dispensing end of the dropper tip,

wherein the first container is at least partially deformable to facilitate dispensing the mixture of the first compound and the fluid upon squeezing and the dropper tip is sized and shaped to dispense a sterilely mixed medication directly from the first container to the patient eye.

2. The system of claim 1 , further comprising:

a protective cap sized and shaped to be removably disposed over the membrane, the protective cap providing additional protection against inadvertent puncture of the membrane and being removable prior to engagement of the sleeve with the collar.

3. The system of claim 1 , wherein the luer lock is sized and shaped to provide removable engagement with a syringe such that a syringe containing a fluid can be engaged with the luer lock and the fluid contained in the syringe can be dispensed into the first container through the fluid communication passage.

4. The system of claim 1 , wherein the collar and the sleeve include threads that permit the removable engagement of the collar and sleeve.

5. The system of claim 1 , wherein the vent includes a one-way valve that permits air in the container to be expelled and does not permit air, microbes and a combination thereof to enter the container from the outside environment.

6. The system of claim 1 , wherein the luer lock is configured to introduce a diluent for mixing with the first compound.

7. The system of claim 1 , wherein the first compound is ceftazidime.

8. The system of claim 1 , wherein the first compound is vancomycin.

9. The system of claim 1 , wherein the dropper tip includes a filter to prevent outflow of at least one of microbes, contaminants, unmixed drug and a combination thereof from the first container into a patient eye.

10. The system of claim 9 , wherein the filter is a 5 micron filter.

11. The system of claim 1 , wherein at least a portion of the first container is translucent such that contents of the first container can be viewed through the translucent portion.

12. The system of claim 1 , wherein at least a first portion of the first container is opaque and at least a second portion is translucent such that contents of the first container can be viewed through the translucent portion.

13. The system of claim 1 , wherein the dropper tip includes a locking mechanism such that the dropper tip can be selectively engaged with the collar in a locking manner to facilitate administration of medication from the dropper tip to an eye of the patient.

14. The system of claim 1 , wherein the patient is a human or non-human animal.